Skip to Content

Nephros Inc NEPH

Morningstar Rating
$2.11 −0.06 (2.77%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NEPH is trading at a 48% discount.
Price
$2.10
Fair Value
$7.72
Uncertainty
Extreme
1-Star Price
$88.75
5-Star Price
$1.62
Economic Moat
Thwh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEPH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.17
Day Range
$2.062.15
52-Week Range
$0.994.04
Bid/Ask
$0.85 / $2.46
Market Cap
$22.25 Mil
Volume/Avg
17,336 / 28,970

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.54
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
27

Valuation

Metric
NEPH
Price/Earnings (Normalized)
Price/Book Value
2.66
Price/Sales
1.54
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NEPH
Quick Ratio
2.75
Current Ratio
3.98
Interest Coverage
−818.50
Quick Ratio
NEPH

Profitability

Metric
NEPH
Return on Assets (Normalized)
−2.07%
Return on Equity (Normalized)
−2.84%
Return on Invested Capital (Normalized)
−2.96%
Return on Assets
NEPH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncGylk$139.2 Bil
BDX
Becton Dickinson & CoRxkgpl$68.7 Bil
ALC
Alcon IncFssfkdn$41.9 Bil
CLPBY
Coloplast A/S ADRLmv$30.5 Bil
WST
West Pharmaceutical Services IncBymn$29.0 Bil
RMD
ResMed IncYghdtt$28.1 Bil
BAX
Baxter International IncTrdlj$21.1 Bil
COO
The Cooper Companies IncVkpfw$20.0 Bil
HOLX
Hologic IncVxvtzkr$17.9 Bil
TFX
Teleflex IncLwwfp$10.2 Bil

Sponsor Center